Minimally Invasive Surgery Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Description
Growth Factors of minimally invasive surgery (MIS) devices Market
The global minimally invasive surgery (MIS) devices market is experiencing robust growth due to the rising preference for less traumatic surgical procedures and continuous technological advancements. According to Fortune Business Insights, the market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.61 billion in 2026. By 2034, the market is expected to reach USD 41.41 billion, registering a CAGR of 8.47% during the forecast period (2026–2034). North America dominated the market in 2025 with a share of 43.18%, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement policies.
Market Overview
Minimally invasive surgery devices are specialized medical instruments used to perform surgical procedures through small incisions or natural body openings. These devices include endoscopic devices, laparoscopic instruments, robotic-assisted systems, guiding devices, inflation devices, and navigation & visualization systems. MIS procedures offer significant advantages over traditional open surgeries, including reduced blood loss, minimal scarring, lower infection risk, shorter hospital stays, and faster patient recovery.
The growing preference for minimally invasive approaches among both patients and healthcare providers is driving widespread adoption across multiple surgical disciplines, including orthopedics, cardiology, gynecology, gastrointestinal surgery, and neurology.
Market Drivers
The rising incidence of chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity is a major factor driving market growth. According to data published in January 2025, nearly 620 million people worldwide live with heart and circulatory diseases, many of whom require surgical intervention. Minimally invasive procedures are increasingly favored due to their ability to reduce postoperative complications and improve clinical outcomes.
Additionally, the increasing number of orthopedic and sports-related injuries is contributing to higher adoption of arthroscopic and minimally invasive orthopedic surgeries. As of 2025, over 4 million arthroscopic knee surgeries are performed annually worldwide, significantly boosting demand for MIS devices.
Market Restraints
Despite strong growth prospects, high costs associated with MIS devices remain a key restraint. Advanced technologies such as robotic surgical systems require substantial upfront investment, often exceeding USD 2.0 million per system, excluding maintenance and training costs. These high expenses limit adoption to large, well-funded hospitals and restrict penetration in rural and resource-limited healthcare settings.
Market Opportunities
The rapid expansion of ambulatory surgery centers (ASCs) presents a major growth opportunity. According to the Ambulatory Surgery Centers Association, over 6,300 Medicare-certified ASCs were operational in the U.S. as of 2024. ASCs increasingly adopt minimally invasive technologies due to their alignment with outpatient care models, cost efficiency, and favorable reimbursement structures. This shift is expected to sustain long-term demand for MIS devices.
Market Challenges
A significant challenge facing the market is the shortage of skilled surgical professionals trained in minimally invasive techniques. According to the American Association of Medical Colleges, the U.S. may face a shortage of up to 30,200 surgeons by 2036. Limited access to specialized training, particularly in developing regions, hampers the widespread adoption of MIS procedures and devices.
Market Trends
Continuous technological advancements are reshaping the MIS landscape. Robotic-assisted surgical systems, AI-powered navigation tools, 3D imaging, and miniaturized instruments are enhancing surgical precision and outcomes. Single-port laparoscopic and natural orifice surgeries are gaining popularity due to reduced scarring and faster recovery, further fueling demand for advanced MIS devices.
Segmentation Insights
By Type: Endoscopic devices dominated the market in 2024 due to increased use in endovascular procedures. Robotic-assisted surgery devices are expected to grow at the fastest CAGR.
By Application: The orthopedic segment led the market in 2024, driven by rising fractures and joint disorders, followed by cardiology and gastrointestinal applications.
By End User: Hospitals & ASCs held the largest share due to advanced infrastructure and higher surgical volumes.
Regional Analysis
North America accounted for USD 8.75 billion in 2025, with the U.S. market expected to reach USD 8.81 billion by 2026.
Europe remains a strong contributor, supported by robotic surgery adoption, with Germany projected to reach USD 1.35 billion by 2026.
Asia Pacific is expected to grow at the fastest rate, driven by aging populations and rising healthcare investments. By 2026, China is projected at USD 1.79 billion, Japan at USD 1.38 billion, and India at USD 0.37 billion.
Competitive Landscape
The market is consolidated, with key players such as Medtronic, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Boston Scientific, Olympus, Stryker, B. Braun, and Intuitive Surgical. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Conclusion
The global minimally invasive surgery devices market is poised for strong expansion, growing from USD 20.27 billion in 2025 to USD 41.41 billion by 2034. Increasing prevalence of chronic diseases, rising adoption of outpatient surgical procedures, and continuous technological innovation are driving market growth. While high costs and workforce shortages remain challenges, expanding ambulatory care infrastructure and advancements in robotic and AI-assisted technologies are expected to shape the future of minimally invasive surgery worldwide.
ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year 2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 8.47% from 2026-2034
Unit Value (USD Billion)
Segmentation By Type
Inflation Devices
Guiding Devices
Endoscopic Devices
Laparoscopic Devices
Robotic Assistive Surgery Devices
Navigation & Visualization Systems
Others
By Application
Cardiology
Gastrointestinal
Orthopedic
Gynecological
Neurology
Dental
Others
By End-user
Hospitals & ASCs
Clinics
Others
By Geography
North America (By Type, Application, End-user, and Country)
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
The global minimally invasive surgery (MIS) devices market is experiencing robust growth due to the rising preference for less traumatic surgical procedures and continuous technological advancements. According to Fortune Business Insights, the market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.61 billion in 2026. By 2034, the market is expected to reach USD 41.41 billion, registering a CAGR of 8.47% during the forecast period (2026–2034). North America dominated the market in 2025 with a share of 43.18%, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement policies.
Market Overview
Minimally invasive surgery devices are specialized medical instruments used to perform surgical procedures through small incisions or natural body openings. These devices include endoscopic devices, laparoscopic instruments, robotic-assisted systems, guiding devices, inflation devices, and navigation & visualization systems. MIS procedures offer significant advantages over traditional open surgeries, including reduced blood loss, minimal scarring, lower infection risk, shorter hospital stays, and faster patient recovery.
The growing preference for minimally invasive approaches among both patients and healthcare providers is driving widespread adoption across multiple surgical disciplines, including orthopedics, cardiology, gynecology, gastrointestinal surgery, and neurology.
Market Drivers
The rising incidence of chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity is a major factor driving market growth. According to data published in January 2025, nearly 620 million people worldwide live with heart and circulatory diseases, many of whom require surgical intervention. Minimally invasive procedures are increasingly favored due to their ability to reduce postoperative complications and improve clinical outcomes.
Additionally, the increasing number of orthopedic and sports-related injuries is contributing to higher adoption of arthroscopic and minimally invasive orthopedic surgeries. As of 2025, over 4 million arthroscopic knee surgeries are performed annually worldwide, significantly boosting demand for MIS devices.
Market Restraints
Despite strong growth prospects, high costs associated with MIS devices remain a key restraint. Advanced technologies such as robotic surgical systems require substantial upfront investment, often exceeding USD 2.0 million per system, excluding maintenance and training costs. These high expenses limit adoption to large, well-funded hospitals and restrict penetration in rural and resource-limited healthcare settings.
Market Opportunities
The rapid expansion of ambulatory surgery centers (ASCs) presents a major growth opportunity. According to the Ambulatory Surgery Centers Association, over 6,300 Medicare-certified ASCs were operational in the U.S. as of 2024. ASCs increasingly adopt minimally invasive technologies due to their alignment with outpatient care models, cost efficiency, and favorable reimbursement structures. This shift is expected to sustain long-term demand for MIS devices.
Market Challenges
A significant challenge facing the market is the shortage of skilled surgical professionals trained in minimally invasive techniques. According to the American Association of Medical Colleges, the U.S. may face a shortage of up to 30,200 surgeons by 2036. Limited access to specialized training, particularly in developing regions, hampers the widespread adoption of MIS procedures and devices.
Market Trends
Continuous technological advancements are reshaping the MIS landscape. Robotic-assisted surgical systems, AI-powered navigation tools, 3D imaging, and miniaturized instruments are enhancing surgical precision and outcomes. Single-port laparoscopic and natural orifice surgeries are gaining popularity due to reduced scarring and faster recovery, further fueling demand for advanced MIS devices.
Segmentation Insights
By Type: Endoscopic devices dominated the market in 2024 due to increased use in endovascular procedures. Robotic-assisted surgery devices are expected to grow at the fastest CAGR.
By Application: The orthopedic segment led the market in 2024, driven by rising fractures and joint disorders, followed by cardiology and gastrointestinal applications.
By End User: Hospitals & ASCs held the largest share due to advanced infrastructure and higher surgical volumes.
Regional Analysis
North America accounted for USD 8.75 billion in 2025, with the U.S. market expected to reach USD 8.81 billion by 2026.
Europe remains a strong contributor, supported by robotic surgery adoption, with Germany projected to reach USD 1.35 billion by 2026.
Asia Pacific is expected to grow at the fastest rate, driven by aging populations and rising healthcare investments. By 2026, China is projected at USD 1.79 billion, Japan at USD 1.38 billion, and India at USD 0.37 billion.
Competitive Landscape
The market is consolidated, with key players such as Medtronic, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Boston Scientific, Olympus, Stryker, B. Braun, and Intuitive Surgical. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Conclusion
The global minimally invasive surgery devices market is poised for strong expansion, growing from USD 20.27 billion in 2025 to USD 41.41 billion by 2034. Increasing prevalence of chronic diseases, rising adoption of outpatient surgical procedures, and continuous technological innovation are driving market growth. While high costs and workforce shortages remain challenges, expanding ambulatory care infrastructure and advancements in robotic and AI-assisted technologies are expected to shape the future of minimally invasive surgery worldwide.
ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year 2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 8.47% from 2026-2034
Unit Value (USD Billion)
Segmentation By Type
Inflation Devices
Guiding Devices
Endoscopic Devices
Laparoscopic Devices
Robotic Assistive Surgery Devices
Navigation & Visualization Systems
Others
By Application
Cardiology
Gastrointestinal
Orthopedic
Gynecological
Neurology
Dental
Others
By End-user
Hospitals & ASCs
Clinics
Others
By Geography
North America (By Type, Application, End-user, and Country)
- U.S.
- Canada
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Middle East & Africa
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
Table of Contents
200 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. 4.1 Fertility Statistics (2025)
- 4.2. 4.2 Regulatory scenario for key countries
- 4.3. 4.3 Recent industry developments such as mergers & acquisitions
- 4.4. 4.4 Key Industry Trends
- 4.5. 4.5 Government policies & their impact on contraceptives industry
- 4.6. 4.6 New Product Launches
- 5. Global Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.3. 5.2.1 Combined Contraceptives (E+P)
- 5.4. 5.2.2 Progestin-only Pills
- 5.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.6. 5.3.1 Hospital Pharmacy
- 5.7. 5.3.2 Retail Pharmacy
- 5.8. 5.3.3 Clinics
- 5.9. 5.3.4 Online Channel
- 5.10. 5.3.5 Public Channel & NGOs
- 5.11. 5.3.6 Others
- 5.12. Market Analysis, Insights and Forecast – By Region
- 5.13. 5.4.1 North America
- 5.14. 5.4.2 Europe
- 5.15. 5.4.3 Asia pacific
- 5.16. 5.4.4 Latin America
- 5.17. 5.4.5 Middle East & Africa
- 6. North America Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Type
- 6.3. 6.2.1 Combined Contraceptives (E+P)
- 6.4. 6.2.2 Progestin-only Pills
- 6.5. Market Analysis – By Distribution Channel
- 6.6. 6.3.1 Hospital Pharmacy
- 6.7. 6.3.2 Retail Pharmacy
- 6.8. 6.3.3 Clinics
- 6.9. 6.3.4 Online Channel
- 6.10. 6.3.5 Public Channel & NGOs
- 6.11. 6.3.6 Others
- 6.12. Market Analysis – By Country
- 6.13. 6.4.1 U.S.
- 6.14. 6.4.2 Canada
- 7. Europe Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Type
- 7.3. 7.2.1 Combined Contraceptives (E+P)
- 7.4. 7.2.2 Progestin-only Pills
- 7.5. Market Analysis – By Distribution Channel
- 7.6. 7.3.1 Hospital Pharmacy
- 7.7. 7.3.2 Retail Pharmacy
- 7.8. 7.3.3 Clinics
- 7.9. 7.3.4 Online Channel
- 7.10. 7.3.5 Public Channel & NGOs
- 7.11. 7.3.6 Others
- 7.12. Market Analysis – By Country/Sub-region
- 7.13. 7.4.1 U.K.
- 7.14. 7.4.2 Germany
- 7.15. 7.4.3 France
- 7.16. 7.4.4 Spain
- 7.17. 7.4.5 Italy
- 7.18. 7.4.6 Scandinavia
- 7.19. 7.4.7 Rest of Europe
- 8. Asia pacific Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Type
- 8.3. 8.2.1 Combined Contraceptives (E+P)
- 8.4. 8.2.2 Progestin-only Pills
- 8.5. Market Analysis – By Distribution Channel
- 8.6. 8.3.1 Hospital Pharmacy
- 8.7. 8.3.2 Retail Pharmacy
- 8.8. 8.3.3 Clinics
- 8.9. 8.3.4 Online Channel
- 8.10. 8.3.5 Public Channel & NGOs
- 8.11. 8.3.6 Others
- 8.12. Market Analysis – By Country/Sub-region
- 8.13. 8.4.1 Japan
- 8.14. 8.4.2 China
- 8.15. 8.4.3 India
- 8.16. 8.4.4 Australia
- 8.17. 8.4.5 Southeast Asia
- 8.18. 8.4.6 Rest of Asia Pacific
- 9. Latin America Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Type
- 9.3. 9.2.1 Combined Contraceptives (E+P)
- 9.4. 9.2.2 Progestin-only Pills
- 9.5. Market Analysis – By Distribution Channel
- 9.6. 9.3.1 Hospital Pharmacy
- 9.7. 9.3.2 Retail Pharmacy
- 9.8. 9.3.3 Clinics
- 9.9. 9.3.4 Online Channel
- 9.10. 9.3.5 Public Channel & NGOs
- 9.11. 9.3.6 Others
- 9.12. Market Analysis – By Country/Sub-region
- 9.13. 9.4.1 Brazil
- 9.14. 9.4.2 Mexico
- 9.15. 9.4.3 Rest of Latin America
- 10. Middle East & Africa Contraceptive Pills Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Type
- 10.3. 10.2.1 Combined Contraceptives (E+P)
- 10.4. 10.2.2 Progestin-only Pills
- 10.5. Market Analysis – By Distribution Channel
- 10.6. 10.3.1 Hospital Pharmacy
- 10.7. 10.3.2 Retail Pharmacy
- 10.8. 10.3.3 Clinics
- 10.9. 10.3.4 Online Channel
- 10.10. 10.3.5 Public Channel & NGOs
- 10.11. 10.3.6 Others
- 10.12. Market Analysis – By Country/Sub-region
- 10.13. 10.4.1 GCC Countries
- 10.14. 10.4.2 South Africa
- 10.15. 10.4.3 Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. Allergan plc
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Pfizer, Inc
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. Merck & Co., Inc.
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. Teva Pharmaceutical Industries
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. Bayer AG
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Janssen Pharmaceutical Company
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. HLL Lifecare Limited
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Mylan N.V.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Piramal Enterprises
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 12. Strategic Recommendations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
